10 Best Growth Stocks to Buy According to Billionaires

5. Insmed Inc. (NASDAQ:INSM)

Rev. Growth Current Year/ Next Year: 29% / 119%

Number of Billionaire Investors: 14

Number of Hedge Fund Holders: 64

Insmed Inc. (NASDAQ:INSM) is one of the 10 best growth stocks to buy according to billionaires. On June 10, Mizuho analyst Graig Suvannavejh reaffirmed his Outperform rating on Insmed and raised the price target from $96 to $110.

The revision follows the encouraging Phase 2b results for Treprostinil Palmitil Inhalation Powder (TPIP) in treating pulmonary arterial hypertension. Suvannavejh describes the data as highly positive, suggesting TPIP could become a leading treatment option in the respective area.

The analyst believes the trial’s success strengthens Insmed’s growth outlook and opens the door for further upside to current earnings estimates. The tone of the note reflects the analyst’s strong confidence in TPIP’s potential and its impact on Insmed’s long-term value.

Insmed Inc. (NASDAQ:INSM) is a global biopharmaceutical company that develops therapies for serious diseases. It has a commercial product, ARIKAYCE, and a pipeline that includes clinical-stage programs, brensocatib, TPIP, and INS1201, as well as pre-clinical research programs.